Patents by Inventor Jeffrey Behrens

Jeffrey Behrens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180280504
    Abstract: The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 4, 2018
    Inventors: Ana Paula Galvao da Silva, Julie DeSander, Jeffrey Behrens, Darius Ghaderi, Mai Zhang, Kristan Meetze
  • Patent number: 9879087
    Abstract: The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: January 30, 2018
    Assignee: SIAMAB THERAPEUTICS, INC.
    Inventors: Julie DeSander, Jeffrey Behrens, Alexey Alexandrovich Lugovskoy
  • Publication number: 20170306046
    Abstract: The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
    Type: Application
    Filed: November 12, 2015
    Publication date: October 26, 2017
    Inventors: Ana Paula Galvao daSilva, Darius Ghaderi, Mai Zhang, Kristan Meetze, Julie DeSander, Jeffrey Behrens, David A. Eavarone, Jillian M. Prendergast, Alexey Alexandrovich Lugovskoy
  • Publication number: 20170305950
    Abstract: The invention provides methods and tools, for example, glycan arrays, for the analysis of glycans and anti-glycan antibodies. Embodiments of the invention may be used to detect proteins, antibodies, diseases and/or pathogenic agents. In other embodiments, methods of the invention are used to develop or optimize arrays and antibodies.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 26, 2017
    Inventors: Ana Paula Galvao da Silva, Mai Zhang, Darius Ghaderi, Julie DeSander, Jeffrey Behrens, Jillian M. Prendergast
  • Publication number: 20160264684
    Abstract: The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them.
    Type: Application
    Filed: October 10, 2014
    Publication date: September 15, 2016
    Applicant: SIAMAB THERAPEUTICS, INC.
    Inventors: Ana Paula Galvao da Silva, Mai Zhang, Darius Ghaderi, Intan Purnajo, Julie DeSander, Jeffrey Behrens
  • Publication number: 20160130356
    Abstract: The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
    Type: Application
    Filed: January 4, 2016
    Publication date: May 12, 2016
    Inventors: Julie DeSander, Jeffrey Behrens
  • Publication number: 20160106799
    Abstract: Embodiments of the present invention provide compositions and methods for the modulation of sialic acid levels. In some embodiments, compositions disclosed herein comprise nutraceuticals as functional agents.
    Type: Application
    Filed: May 29, 2014
    Publication date: April 21, 2016
    Applicant: SIAMAB THERAPEUTICS, INC.
    Inventors: Mai Zhang, Darius Ghaderi, Jeffrey Behrens, Julie DeSander, Ajit Varki
  • Publication number: 20140178365
    Abstract: The present invention provides glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them.
    Type: Application
    Filed: October 10, 2013
    Publication date: June 26, 2014
    Applicant: SIALIX INC
    Inventors: Darius Ghaderi, Ana Paula Galvao da Silva, Jeffrey Behrens, Julie Hermann, Nancy Hurtado-Ziola
  • Publication number: 20060243162
    Abstract: A method of preparing a fountain solution, a system for blending two or more concentrate components of a fountain solution, concentrate compositions, and articles of manufacture or kits comprising the concentrate compositions are provided. The method comprises combining at least two fluid concentrates that comprise the components of the fountain solution at effective proportions with water to produce the fountain solution composition containing a predetermined concentration of ingredients. In one embodiment, the method comprises combining an acidic film-forming polymer concentrate and a surface tension reducing (wetting) concentrate with water to form the fountain solution. The method preferably utilizes a proportioning pump for metering amounts of the component concentrates of the fountain solution into a water flow.
    Type: Application
    Filed: July 12, 2006
    Publication date: November 2, 2006
    Applicant: RBP Chemical Technology, Inc.
    Inventors: Raymond Hanneman, Jeffrey Behrens, Salvatore Viverito